Does methotrexate confer a significant advantage over misoprostol alone for early medical abortion?
In this real-use setting, methotrexate appears to confer a significant advantage over misoprostol alone for early medical abortion. This finding is important for settings where mifepristone remains unavailable. Additional factors such as gestational age limits and patient preference should be considered in regimen selection.
Irrespective of its effects on antiepileptic drug disposition, being pregnant per se seems to impair epileptic seizure control.